The effect of ovarian cancer expression of altered p53 and/or WT1 is associated with an increased risk of death after adjusting for both age and FIGO stage when compared to patients with tumours with normal p53 expression and a lack of nuclear WT1 expression (hazard ratio = 2.4). Here, TP53 is linked to ovarian carcinoma.